Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.36Price to Book
VS
Market
Sector
Industry
History
$ 7.8Close
$ 3.84 - $ 23.39 52-Week Range
Ticker Information
Ticker
MYGNCompany Name
MYRIAD GENETICS INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQMYRIAD GENETICS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
MYGN - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 388.1M | $ 527.56M | 1.36 |
| 3/31/2025 | $ 704.9M | $ 393.6M | 0.56 |
| 12/31/2024 | $ 701.1M | $ 979.75M | 1.4 |
| 9/30/2024 | $ 731.7M | $ 1.58B | 2.17 |
| 6/30/2024 | $ 740.5M | $ 2.42B | 3.27 |
| 3/31/2024 | $ 760M | $ 2.17B | 2.85 |
| 12/31/2023 | $ 783.2M | $ 1.94B | 2.48 |
| 9/30/2023 | $ 683.4M | $ 1.46B | 2.14 |
| 6/30/2023 | $ 735.2M | $ 1.58B | 2.15 |
| 3/31/2023 | $ 835.2M | $ 1.72B | 2.06 |
Key Performance Insights, Last 5 Years
- MYRIAD GENETICS INC's latest trailing twelve months (TTM) P/B stands at 1.41.
- Over the past 5 years, MYRIAD GENETICS INC's average P/B has been 2.11.
- The median P/B for MYRIAD GENETICS INC during this period was 2.14
- MYRIAD GENETICS INC reached its highest P/B over the past 5 years at 3.27.
- The lowest P/B recorded by MYRIAD GENETICS INC in the same timeframe 0.56
MYRIAD GENETICS INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for MYRIAD GENETICS INC is calculated as follows: Market Cap [ $ 1.28B ] / Equity [ $ 909.3M ]
(=) P/B [ 1.41 ] MYGN - Price to Book, Last 5 years
0.56
Minimum
Mar 31, 2025
3.27
Maximum
Jun 30, 2024
2.11
Average
2.14
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.29 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.29 |
| median | 1.63 |
| std | 1.81 |